M. O. Karlsson - Concepedia

Author

M. O. Karlsson

Uppsala University

Also Known As

M KARLSSON, M Karlsson, M O Karlsson, M. Karlsson, M. O. Karlsson, M.O. Karlsson, Mats O. Karlsson

Publications

757

Citations

H-Index

Concepts

All Affiliations

Uppsala University Medical Products Agency Uppsala University Hospital

About

M. O. Karlsson is an author at Uppsala University specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	288
2	Pharmacology	4	4	259
3	Public Health	1	1	29
4	Epidemiology	1	1	29
5	Metabolism	1	1	16

M. O. Karlsson

Publications

732

Citations

H-Index

Page 1

	Year	Citations
Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients M. O. Karlsson, E. Niclas Jonsson, Curtis G. Wiltse, Journal of Pharmacokinetics and Biopharmaceutics	1998	150
Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles Lia van Zuylen, M. O. Karlsson, Jaap Verweij, Cancer Chemotherapy and Pharmacology NanomedicinePolymer-drug ConjugateMedicineMicellePaclitaxel Encapsulation	2001	133
Semiphysiological Model for the Time Course of Leukocytes after Varying Schedules of 5-Fluorouracil in Rats Lena E. Friberg, Agneta Freijs, Marie Sandström, Journal of Pharmacology and Experimental Therapeutics	2000	81
Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients Anja Henningsson, Alex Sparreboom, Marie Sandström, European Journal of Cancer MedicinePharmacologyPopulation Pharmacokinetic ModellingPharmacotherapyTotal Plasma Concentrations	2003	78
Variable expression of CYP and Pgp genes in the human small intestine Michael K. Lindell, M. O. Karlsson, Hans Lennernäs, European Journal of Clinical Investigation	2003	74
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of Pharmacokinetics and Pharmacodynamics Tony Rydberg, Anders Jönsson, M. O. Karlsson, British Journal of Clinical Pharmacology	1997	65
Nonlinearity detection: Advantages of nonlinear mixed-effects modeling E. Niclas Jonsson, M. O. Karlsson, Janet R. Wade AAPS PharmSci	2000	50
Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days. H Hanhijärvi, Inkeri Elomaa, M. O. Karlsson, PubMed Medicinal ChemistryUrologyConsecutive DaysPharmacokinetic ModelingProstatic Cancer	1989	32
Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children Michelle Viljoen, M. O. Karlsson, T. M. Meyers, European Journal of Clinical Pharmacology T PolymorphismHuman RetrovirusGenetic EpidemiologyAntiviral TherapyVirology	2011	29
Model for Time Dependency of Cytotoxic Effect of CHS 828 in Vitro Suggests Two Different Mechanisms of Action Saadia Hassan, Elin Jonsson, Rolf Larsson, Journal of Pharmacology and Experimental Therapeutics	2001	24

Page 1